期刊文献+

Fe^(2+)对人脐静脉平滑肌细胞增殖及分泌基质金属蛋白酶-2的影响

Effects of Fe^(2+) on proliferation and secretion of MMP-2 in umbilical venous smooth muscle cells
下载PDF
导出
摘要 目的探讨Fe2+对高糖预孵育的人脐静脉平滑肌细胞(human umbilical vascular smooth muscle cell,HUSMC)增殖及基质金属蛋白酶-2(MMP-2)分泌的影响。方法取高糖DMEM培养液培养的原代HUSMC(3~5代),分为空白对照组(加DMEM培养液)、A组(100 mg/L Fe2+培养液)、B组(50 mg/L Fe2+培养液)、C组(25 mg/L Fe2+培养液)、D组(12.5 mg/L Fe2+培养液)、E组(6.25 mg/L Fe2+培养液)。干预24 h后,MTT比色法测定细胞增殖,ELISA检测MMP-2含量,激光共聚焦显微镜测定细胞内Ca2+浓度。结果除E组外其他各Fe2+组促血管平滑肌细胞(VSMC)增殖作用均高于空白对照组(P<0.01),A组、B组作用最强;各浓度Fe2+组MMP-2含量均高于空白对照组(P<0.05);A组细胞内Ca2+荧光强度较空白对照组强(P<0.01)。结论Fe2+能明显促进VSMC增殖,并促进分泌MMP-2,升高细胞内Ca2+浓度。 Objective To investigate the effects of Fe^2+ on proliferation and secretion of MMP-2 in HUVSMC incubated in high glucose DMEM. Methods Primary cultures of HUVSMCs incubated in the high glucose DMEM (Passage 3~5) ,were divided into control group and groups in cubated with Fe^2+ at five different concentrations(100 mg/L,50 mg/L,25 mg/L,12.5 mg/L,6.25 mg/L). After 24 h of intervention, HUVSMCs proliferation was assessed with MTT method, MMP-2 secretion was measured with ELISA, and the intracellular Ca2+ concentration was assessed by laser confocal microscopy. Results Compared with the control group, HUVSMCs proliferation in 12.5~ 100 mg/L Fe^2+ treatment group was increased (P 〈0.05);the secretion of MMP-2 was promoted in all Fe^2+ concentration groups (P 〈0.05) ;and the intracellular Ca^2+ concentration of HUVSMC was augmented by 100 mg/L Fe^2+ treatment (P 〈0.01). Conclusions Fe^2+ can stimulate the proliferation of VSMC, and increase the intracellular Ca^2+ as well as the secretion of MMP-2.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第6期451-453,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 脐静脉 肌细胞 平滑肌 细胞增殖 明胶酶A 支架 umbrlical veins myocytes, smooth muscle cell proliferation gelatinase A stents
  • 相关文献

参考文献10

  • 1May T, Mueller PP, Weich H, et al. Establishment of murine cell lines by constitutive and conditional immortalization. J Biotechnol, 2005,20 : 99-110.
  • 2Mueller PP, May T, Perz A, et al. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials, 2006,27 : 2193- 2200.
  • 3Moussa l,Leon MB,Bairn DS,et al. Impact of sirolimus-eluting stents on outcome in diabetic patients :a SIRIUS(SIRoll-mUScoated Bx Velocity balloon-expandable stent in the treatment of patients with the novo coronary artery lesions) substudy. Circulation, 2004,109:2273-2278.
  • 4Heper G, Durmaz T, Murat SN,et al. Clinical and angiographic outcomes of diabetic patients after coronary stenting: a comparison of native vessel stent restenosis rates in different diabetic subgroups. Angiology,2002,53 : 287-295.
  • 5Coolong A,Kuntz RE. Understanding the drug-eluting stent trial. Am J Cardiol, 2007,100 : 17K-24K.
  • 6王智慧,孟晓萍,崔艳,王莉,李方连,贺晓楠,侯文丽.基质金属蛋白酶2(MMP2)对血管平滑肌增生迁移的影响[J].中国实验诊断学,2006,10(7):789-790. 被引量:8
  • 7Dolmetseh RE, Lewis RS,GoAnow CC, et al. Differential activation of transcription factors induced by Ca^2+ response amplitude and duration. Nature, 1997,386 : 855-858.
  • 8Suzuki J, Iwai M, Nakagami H, et al. Role of angiotensin Ⅱ-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation, 2002,106 : 847-853.
  • 9Dayi SU, Tartan Z, Terzi S, et al. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Heart Surg Forum,2005,8 : 373-377.
  • 10Bers DM,Perez-Reyes E. Ca^2+ channels in cardiac myocytes: structure and function in Ca^2+ influx and intraceliular Ca^2+ release. Cardiovasc Res, 1999,42:339-360.

二级参考文献7

  • 1Mcbride W,Lange RA,Hillis LD.Restensis after successful coroanary angioplasty[J].N Eng Jour,1988,318:1734.
  • 2Nobuyoshi M,Kimura T,Nosaka H,et al.Restenosis after successful percutaneous transluminal coronary angioplasty:serial angiographic follow-up of 229 patients[J].J Am Coll Cardiol 1988,12:616.
  • 3Popma JJ,Califf RM,Topol EJ.Clinical trials of restenosis after coronary angioplasty[J].Circulation,1991,84:1426.
  • 4Yenkins G,Crow M,Michael T,et al.Increased expression of membrane Type Matrix Metalloproteinas preferential localization of Matrix Metalloproteinase-2 to Neointima of balloon-injury rat carotid arteries[J].Circulation,1998,97:82.
  • 5Laurent J.Feldman,Mikael Mazighi,Aliocha Scheuble,Jean-Fran? ois Deux,Edoardo De Benedetti,Cecile Badier-Commander,Elisabeth Brambilla,Dominique Henin,P.Gabriel Steg,and Marie-Paule Jacob Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hyperchdesterolemic Rabbit[J].Circ Jun,2001,103:3117.
  • 6Tyagi SC,Meyer L,Schmailtz RA,Reddy HK,Voelker DJ.Proteinases and restenosis in the human coronary artery; extracellular matrix production exceeds the expression of proteolytic activity[J].Arteriosclerosis,1995,116:43.
  • 7Alicia Rodríguez-Pla,Josep A.Bosch-Gil,Jose Rossello-Urgell,et al.Stone,and Miquel Vilardell-Tarres Metalloproteinase-2 and -9 in Giant Cell Arteritis:Involvement in Vascular Remodeling[J].Circ Jul,2005,112:264.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部